Other languages Kyowa Corporation

Equities

Market Closed - Japan Exchange Other stock markets 07:00:00 02/07/2024 BST			5-day change	1st Jan Change
884 ^JPY	-0.11%		-1.01%	+9.54%

06-05	Kyowa Kirin Repurchases 3.3 Million Shares in May	MT
05-07	Kyowa Kirin's Profit Up 15% in Q1	MT

Kyowa Kirin's Profit Up 15% in Q1	05-07
BridgeBio Pharma Shares Decline After Q1 Financial Results	05-02
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	03-25
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	03-25
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	03-20
EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria	03-18
US approves first gene therapy for children with rare genetic disease	03-18
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares	03-05
China Deflation, Bank of Japan Roil Asian Stock Markets	02-08
MÄRKTE ASIEN/Tokio sehr fest auf 34-Jahreshoch - Softbank mit Kurssprung	02-08
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar	02-08
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost	02-08
BridgeBio Pharma Unit to Grant Kyowa Kirin License for Infigratinib in Japan	02-07
Kyowa Kirin's Profit Up 52% in Fiscal 2023	02-07
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January	01-26
Aosaikang Pharmaceutical Registers Breast Cancer Drug	01-23
Kyowa Kirin’s Attributable Profit up 8.8% in Nine Months Ended Sept. 30 on Gain on Sales of Share and Valuation	11-02
LATE BRIEFING - Unternehmen und Märkte	30/10/23
MIDDAY BRIEFING - Unternehmen und Märkte	30/10/23
MÄRKTE ASIEN/Uneinheitlich - Nikkei vor BoJ-Entscheid schwächer	30/10/23

No results for this search